semaglutide for chronic kidney disease and Long-term outcomes of in obesity cardiovascular in the SELECT trial FDA Approves Semaglutide to Reduce – Ozempic picks up FDA indication

Never Share an Semaglutide Pen Between Patients Semaglutide pens must never be shared between patients, even if the needle is changed

(2.4) Dosage Forms and Strengths Contraindications Warnings and Precautions Never share a TOUJEO SoloStar or TOUJEO Max SoloStar single-patient-use prefilled pen between patients, even if the needle is changed

Our job is to evaluate you honestly, explain what the evidence says, and recommend a plan only if the potential benefits outweigh the risks for you as an individual patient

Any medication discussion must follow current law and patient-specific need.

Since then, semaglutide has grown in popularity with the help of social media and celebrities